Bayer Aktiengesellschaft's Form 4 filing
Senti Biosciences Holdings, Inc. (SNTI) · filed Dec 11, 2024
- Accession no.
- 0001578563-24-000493
- Filed
- Dec 11, 2024, 7:38 PM ET
- Trade date
- Dec 9, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bayer AktiengesellschaftCIK 0001144145 | 10% Owner |
| Bayer Healthcare LLCCIK 0001231517 | 10% Owner |
| Bayer World Investments B.V.CIK 0001820027 | 10% Owner |
| Bayer US Holding LPCIK 0001965754 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The reported securities include shares of Series A and warrants purchased by the reporting person for $2,250 per unit. Each unit consists of one share of Series A, convertible into 1,000 shares of the Issuer's common stock, and accompanying warrant coverage to purchase 1,500 shares of the Issuer's common stock for each share of Series A purchased.
Referenced by the price of 2 transactions in Table II.